Disclaimer: This article is for informational purposes only and does not constitute financial advice.
Star Health & Allied Insurance's stock has gained strong momentum, trading at around ₹421.65 as of May 16, 2025, marking six straight days of gains and outperforming the broader market.
The stock is above its 5-, 20-, 50-, and 100-day moving averages, showing short-term strength, but remains below the 200-day average, indicating some long-term caution.
Nuvama upgraded the stock from 'Hold' to 'Buy' with a target price of ₹440, suggesting a potential 27% upside. The company benefits from India's fast-growing health insurance market, expanding at a 19% CAGR.
However, the stock's year-to-date performance is still negative and has been volatile. Investors should be aware of risks before making decisions.
